Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Viking Therapeutics, Inc. - Common Stock
(NQ:
VKTX
)
27.75
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Therapeutics, Inc. - Common Stock
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
32
33
Next >
Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?
↗
December 21, 2024
Via
The Motley Fool
My Top 10 Stocks to Buy for 2025
↗
December 21, 2024
Via
The Motley Fool
Why Viking Therapeutics Tumbled by More Than 10% This Week
↗
December 20, 2024
Via
The Motley Fool
Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up
↗
December 20, 2024
Today's sell-off in Novo Nordisk may be the buying opportunity you've been waiting for.
Via
The Motley Fool
Stock Market Tumbles, Treasury Yields Soar On Fed Rate Outlook: Weekly Review
↗
December 20, 2024
Micron, Vertex, Novo Nordisk and Nike were notable losers on news.
Via
Investor's Business Daily
Topics
Economy
Looking Into Viking Therapeutics's Recent Short Interest
↗
December 20, 2024
Via
Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
↗
December 16, 2024
Via
Benzinga
Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump.
↗
December 20, 2024
Eli Lilly and Viking Therapeutics jumped on Novo's setback.
Via
Investor's Business Daily
From Powell To Profits: Strategic Stock Picks Amid Market Uncertainty
↗
December 19, 2024
Yesterday's market movement aligned perfectly with expectations, as the FOMC meeting drove significant volatility.
Via
Talk Markets
Topics
Stocks / Equities
What's Going On With Viking Therapeutics Stock On Wednesday?
↗
December 18, 2024
Merck partners with Hansoh Pharma for GLP-1 drug development, while analysts highlight Viking's obesity assets as key for future growth.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
December 18, 2024
Via
Benzinga
Merck Joins The Weight-Loss Race, Inking $2.01 Billion Deal To Take On Eli Lilly, Pfizer, Roche
↗
December 18, 2024
Under the deal's terms, Hansoh Pharma receives $112 million up front and a potential $1.9 billion in milestone payments.
Via
Investor's Business Daily
How Is The Market Feeling About Viking Therapeutics?
↗
November 22, 2024
Via
Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
↗
December 16, 2024
Via
Benzinga
Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf?
↗
December 16, 2024
The weight-loss drugs space continues to heat up. Here's the latest news from the segment.
Via
Investor's Business Daily
Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030
↗
December 16, 2024
Via
The Motley Fool
2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street
↗
December 15, 2024
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
↗
December 10, 2024
Via
Benzinga
Warning: This Skyrocketing Stock Has a Hidden Risk
↗
December 10, 2024
Via
The Motley Fool
Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?
↗
December 05, 2024
Via
The Motley Fool
After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now?
↗
December 03, 2024
Via
The Motley Fool
2 Disruptive Growth Stocks With Room to Run
↗
December 03, 2024
Via
The Motley Fool
This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
December 02, 2024
Via
Benzinga
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
↗
November 29, 2024
Analysts are concerned about Viking's ability to compete in the lucrative obesity drug market, dominated by Eli Lilly and Novo Nordisk.
Via
Benzinga
Here's Yet Another Reason to Buy Viking Therapeutics Stock Like There's No Tomorrow
↗
November 28, 2024
Via
The Motley Fool
Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs
↗
November 26, 2024
The Biden Administration's proposal expands Medicare and Medicaid coverage for anti-obesity drugs, cutting costs for millions while addressing the obesity crisis.
Via
Benzinga
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst
↗
November 25, 2024
Via
The Motley Fool
3 Monster Stocks in the Making
↗
November 23, 2024
Via
The Motley Fool
Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk Investors Worry?
↗
November 22, 2024
Robert F. Kennedy hasn't overtly commented on how he would handle GLP-1 drugs. But there are hints.
Via
Investor's Business Daily
Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs
↗
November 20, 2024
Viking Therapeutics' Phase 2b results show VK2809's efficacy in treating NASH, with significant liver fat reductions, NASH resolution, and fibrosis improvement.
Via
Benzinga
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
